Dec 30, 2021
As we continue our Cholangiocarcinoma Series I am excited to welcome, Peter Langmuir, M.D., Group Vice President, Oncology Targeted Therapies, Incyte.
Peter Langmuir, M.D. is Group Vice President of Oncology Targeted Therapeutics at Incyte.
Dr. Langmuir earned his medical degree at the Yale University School of...
Dec 30, 2021
As we continue our Cholangiocarcinoma Series I am excited to welcome, Melinda Bachini Director of Advocacy, Cholangiocarcinoma Foundation.
Melinda Bachini is a 12-year survivor of cholangiocarcinoma. She was diagnosed in 2009 with Stage IV intrahepatic cholangiocarcinoma. Her treatments have included: Liver...
Dec 20, 2021
As we continue our Cholangiocarcinoma Series I am excited to welcome to the show, Milind Javle, M.D.
Milind Javle is a medical oncologist from Houston, TX. He is currently the Hubert L. and Olive Stringer Professor at UT MD Anderson Cancer Center, he is also the current chair, NCI Task Force, Hepatobiliary Cancers,...
Dec 16, 2021
As we kick off our Cholangiocarcinoma Series I am excited to welcome to the show, Stacie Lindsey, Founder and CEO of the Cholangiocarcinoma Foundation.
Stacie Lindsey is the Founder and Chief Executive Officer of the Cholangiocarcinoma Foundation (CCF). She and the Foundation were the first cancer advocacy organization...
Dec 15, 2021